Annual total expenses:
$202.10M+$53.17M(+35.70%)Summary
- As of today (June 23, 2025), CLDX annual total expenses is $202.10 million, with the most recent change of +$53.17 million (+35.70%) on December 31, 2024.
- During the last 3 years, CLDX annual total expenses has risen by +$128.30 million (+173.85%).
- CLDX annual total expenses is now at all-time high.
Performance
CLDX Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$63.43M+$6.23M(+10.89%)Summary
- As of today (June 23, 2025), CLDX quarterly total expenses is $63.43 million, with the most recent change of +$6.23 million (+10.89%) on March 31, 2025.
- Over the past year, CLDX quarterly total expenses has increased by +$22.67 million (+55.61%).
- CLDX quarterly total expenses is now at all-time high.
Performance
CLDX Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
CLDX Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.7% | +55.6% |
| 3 y3 years | +173.8% | +164.7% |
| 5 y5 years | +247.9% | +312.9% |
CLDX Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +173.8% | at high | +164.7% |
| 5 y | 5-year | at high | +254.6% | at high | +379.4% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
CLDX Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $63.43M(+10.9%) |
| Dec 2024 | $202.10M(+35.7%) | $57.20M(+3.4%) |
| Sep 2024 | - | $55.32M(+13.3%) |
| Jun 2024 | - | $48.81M(+19.8%) |
| Mar 2024 | - | $40.76M(+3.8%) |
| Dec 2023 | $148.93M(+36.1%) | $39.26M(-8.2%) |
| Sep 2023 | - | $42.76M(+27.7%) |
| Jun 2023 | - | $33.47M(+0.1%) |
| Mar 2023 | - | $33.44M(+13.4%) |
| Dec 2022 | $109.45M(+48.3%) | $29.50M(+5.0%) |
| Sep 2022 | - | $28.10M(+0.8%) |
| Jun 2022 | - | $27.89M(+16.3%) |
| Mar 2022 | - | $23.97M(+14.6%) |
| Dec 2021 | $73.80M(+29.5%) | $20.92M(+8.0%) |
| Sep 2021 | - | $19.38M(+16.3%) |
| Jun 2021 | - | $16.66M(-1.1%) |
| Mar 2021 | - | $16.84M(+19.9%) |
| Dec 2020 | $56.99M(-1.9%) | $14.05M(-2.1%) |
| Sep 2020 | - | $14.35M(+8.4%) |
| Jun 2020 | - | $13.23M(-13.9%) |
| Mar 2020 | - | $15.36M(+13.3%) |
| Dec 2019 | $58.10M(-32.4%) | $13.56M(-6.5%) |
| Sep 2019 | - | $14.50M(+3.7%) |
| Jun 2019 | - | $13.99M(-12.8%) |
| Mar 2019 | - | $16.05M(+3.3%) |
| Dec 2018 | $85.94M(-29.6%) | $15.54M(-0.6%) |
| Sep 2018 | - | $15.64M(-42.2%) |
| Jun 2018 | - | $27.07M(-2.2%) |
| Mar 2018 | - | $27.69M(-6.4%) |
| Dec 2017 | $122.07M(-12.6%) | $29.58M(+7.6%) |
| Sep 2017 | - | $27.48M(-13.5%) |
| Jun 2017 | - | $31.76M(-4.5%) |
| Mar 2017 | - | $33.25M(-9.5%) |
| Dec 2016 | $139.70M(+3.5%) | $36.73M(+14.0%) |
| Sep 2016 | - | $32.21M(-4.6%) |
| Jun 2016 | - | $33.76M(-8.8%) |
| Mar 2016 | - | $37.01M(+5.0%) |
| Dec 2015 | $135.02M(+7.1%) | $35.23M(+5.5%) |
| Sep 2015 | - | $33.40M(-4.4%) |
| Jun 2015 | - | $34.93M(+11.0%) |
| Mar 2015 | - | $31.47M(-6.1%) |
| Dec 2014 | $126.02M(+47.3%) | $33.53M(+6.6%) |
| Sep 2014 | - | $31.44M(+7.9%) |
| Jun 2014 | - | $29.14M(-8.7%) |
| Mar 2014 | - | $31.91M(+40.3%) |
| Dec 2013 | $85.55M(+23.5%) | $22.73M(-6.2%) |
| Sep 2013 | - | $24.25M(+29.3%) |
| Jun 2013 | - | $18.75M(-5.3%) |
| Mar 2013 | - | $19.82M(-1.9%) |
| Dec 2012 | $69.28M(+31.5%) | $20.20M(+13.1%) |
| Sep 2012 | - | $17.86M(+15.3%) |
| Jun 2012 | - | $15.50M(-1.4%) |
| Mar 2012 | - | $15.72M(+6.1%) |
| Dec 2011 | $52.66M(-1.1%) | $14.82M(+7.1%) |
| Sep 2011 | - | $13.84M(+17.0%) |
| Jun 2011 | - | $11.83M(-2.8%) |
| Mar 2011 | - | $12.17M(-26.5%) |
| Dec 2010 | $53.25M(+1.2%) | $16.55M(+46.0%) |
| Sep 2010 | - | $11.34M(-7.4%) |
| Jun 2010 | - | $12.24M(-6.7%) |
| Mar 2010 | - | $13.12M(-29.2%) |
| Dec 2009 | $52.63M(+27.0%) | $18.52M(+65.6%) |
| Sep 2009 | - | $11.19M(-1.9%) |
| Jun 2009 | - | $11.41M(-1.0%) |
| Mar 2009 | - | $11.52M(+8.4%) |
| Dec 2008 | $41.46M(+145.1%) | $10.63M(-2.8%) |
| Sep 2008 | - | $10.94M(-11.2%) |
| Jun 2008 | - | $12.32M(+62.8%) |
| Mar 2008 | - | $7.57M(+62.0%) |
| Dec 2007 | $16.91M(-14.1%) | $4.67M(+5.1%) |
| Sep 2007 | - | $4.45M(+28.9%) |
| Jun 2007 | - | $3.45M(-20.7%) |
| Mar 2007 | - | $4.35M(-2214.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $19.69M(-10.3%) | -$205.60K(-103.2%) |
| Sep 2006 | - | $6.48M(-5.1%) |
| Jun 2006 | - | $6.83M(+3.7%) |
| Mar 2006 | - | $6.59M(+34.1%) |
| Dec 2005 | $21.95M(+7.4%) | $4.91M(-10.9%) |
| Sep 2005 | - | $5.51M(-0.6%) |
| Jun 2005 | - | $5.54M(-7.5%) |
| Mar 2005 | - | $5.99M(-5.6%) |
| Dec 2004 | $20.44M(+24.9%) | $6.34M(+46.0%) |
| Sep 2004 | - | $4.35M(-11.1%) |
| Jun 2004 | - | $4.89M(-2.2%) |
| Mar 2004 | - | $4.99M(+33.4%) |
| Dec 2003 | $16.37M(-22.6%) | $3.74M(-10.5%) |
| Sep 2003 | - | $4.18M(-2.1%) |
| Jun 2003 | - | $4.27M(+2.6%) |
| Mar 2003 | - | $4.17M(-5.3%) |
| Dec 2002 | $21.14M(-24.3%) | $4.40M(-11.2%) |
| Sep 2002 | - | $4.96M(-16.9%) |
| Jun 2002 | - | $5.97M(+2.8%) |
| Mar 2002 | - | $5.81M(-28.0%) |
| Dec 2001 | $27.91M(+72.2%) | $8.06M(+10.4%) |
| Sep 2001 | - | $7.31M(+4.7%) |
| Jun 2001 | - | $6.98M(+25.9%) |
| Mar 2001 | - | $5.54M(+0.4%) |
| Dec 2000 | $16.20M(+20.7%) | $5.52M(+23.3%) |
| Sep 2000 | - | $4.48M(+42.6%) |
| Jun 2000 | - | $3.14M(+2.8%) |
| Mar 2000 | - | $3.06M(-22.2%) |
| Dec 1999 | $13.43M(+32.9%) | $3.93M(+30.9%) |
| Sep 1999 | - | $3.00M(-9.1%) |
| Jun 1999 | - | $3.30M(0.0%) |
| Mar 1999 | - | $3.30M(-8.3%) |
| Dec 1998 | $10.10M(+13.5%) | $3.60M(+33.3%) |
| Sep 1998 | - | $2.70M(+42.1%) |
| Jun 1998 | - | $1.90M(0.0%) |
| Mar 1998 | - | $1.90M(-9.5%) |
| Dec 1997 | $8.90M(-31.0%) | $2.10M(-4.5%) |
| Sep 1997 | - | $2.20M(-15.4%) |
| Jun 1997 | - | $2.60M(+23.8%) |
| Mar 1997 | - | $2.10M(-30.0%) |
| Dec 1996 | $12.90M(-18.4%) | $3.00M(+25.0%) |
| Sep 1996 | - | $2.40M(-47.8%) |
| Jun 1996 | - | $4.60M(+64.3%) |
| Mar 1996 | - | $2.80M(-31.7%) |
| Dec 1995 | $15.80M(-4.2%) | $4.10M(0.0%) |
| Sep 1995 | - | $4.10M(+7.9%) |
| Jun 1995 | - | $3.80M(-2.6%) |
| Mar 1995 | - | $3.90M(+21.9%) |
| Dec 1994 | $16.50M(-10.3%) | $3.20M(-20.0%) |
| Sep 1994 | - | $4.00M(-16.7%) |
| Jun 1994 | - | $4.80M(+4.3%) |
| Mar 1994 | - | $4.60M(-2.1%) |
| Dec 1993 | $18.40M(+62.8%) | $4.70M(-6.0%) |
| Sep 1993 | - | $5.00M(+8.7%) |
| Jun 1993 | - | $4.60M(+4.5%) |
| Mar 1993 | - | $4.40M(+2.3%) |
| Dec 1992 | $11.30M(-26.6%) | - |
| Oct 1992 | - | $4.30M(+10.3%) |
| Jul 1992 | - | $3.90M(-9.3%) |
| Apr 1992 | - | $4.30M(+10.3%) |
| Apr 1992 | $15.40M(+5.5%) | - |
| Jan 1992 | - | $3.90M(+2.6%) |
| Oct 1991 | - | $3.80M(+11.8%) |
| Jul 1991 | - | $3.40M(-10.5%) |
| Apr 1991 | $14.60M(+14.1%) | $3.80M(+5.6%) |
| Jan 1991 | - | $3.60M(0.0%) |
| Oct 1990 | - | $3.60M(-2.7%) |
| Jul 1990 | - | $3.70M(+12.1%) |
| Apr 1990 | $12.80M(+36.2%) | $3.30M(-10.8%) |
| Jan 1990 | - | $3.70M |
| Apr 1989 | $9.40M(+42.4%) | - |
| Apr 1988 | $6.60M(+73.7%) | - |
| Apr 1987 | $3.80M(+90.0%) | - |
| Apr 1986 | $2.00M | - |
FAQ
- What is Celldex Therapeutics annual total expenses?
- What is the all time high annual total expenses for Celldex Therapeutics?
- What is Celldex Therapeutics annual total expenses year-on-year change?
- What is Celldex Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly total expenses year-on-year change?
What is Celldex Therapeutics annual total expenses?
The current annual total expenses of CLDX is $202.10M
What is the all time high annual total expenses for Celldex Therapeutics?
Celldex Therapeutics all-time high annual total expenses is $202.10M
What is Celldex Therapeutics annual total expenses year-on-year change?
Over the past year, CLDX annual total expenses has changed by +$53.17M (+35.70%)
What is Celldex Therapeutics quarterly total expenses?
The current quarterly total expenses of CLDX is $63.43M
What is the all time high quarterly total expenses for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly total expenses is $63.43M
What is Celldex Therapeutics quarterly total expenses year-on-year change?
Over the past year, CLDX quarterly total expenses has changed by +$22.67M (+55.61%)